Drugs / Indocyanine green (ICG)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT03927651 | Jun 2019 → Nov 2022 | adenomyosis, endometriosis, leiomyoma | Northwestern University | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Indocyanine green (ICG) | “Indocyanine green (ICG)” NCT03927651 ↗ |
| Known as | ICG | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03927651 ↗ |
| Route | Intravenous | “ICG will be injected intravenously” NCT03927651 ↗ |